Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TLK286 in metastatic breast cancer
NCT00035841Phase 2Completed
- Sponsor
- Telik, Inc.
- Start
- Apr 2002
- Primary completion
- Jul 2004
- Modality
- DNA Intercalators/Alkylators, Peptides, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of canfosfamide in breast cancer, sponsored by Telik, Inc.. Started Apr 2002; status: completed.
02
Drugs
canfosfamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00035841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00035841.